The big reshuffle of the generic drug market is on the horizon, and the corporate crisis has not been evaluated

[
dynamic pharmaceutical industry network Recently, the Shanghai Sunshine procurement network bursts of two announcements were demanding the closure of state Medicare drug procurement and drug-free purchases at their own expense records, the expense involved in 871 drug and the 1310 Medicare drugThe industry believes that this means there are a large number of drugs is about to withdraw from the Shanghai hospital marketSpecifically, the two documents issued by the Shanghai Pharmaceutical involved a total of 2181, of which Medicare drug 1310, 871 drugs at their own expense, include ribavirin, sildenafil citrate Africa, tadalafil stars such varieties, including children paracetamol and amantadine hydrochloride granules, children paracetamol Huang Min particles and one hundred children cough syrup pediatric medicine, coverage is very broadIn fact, this is not the first time in Shanghai to make the decision to close without purchasing records of state drug purchase, while not only Shanghai and is hanging kicked out of a large number of drugsIt is understood that, in June 2017, Shanghai Sunshine medicine procurement network will be issued a notice that the pharmaceutical drugs within the dynamic range of 2016 full-year adjusted without purchasing records of the city on the sun deck, a total of 8763 drugs pause hanging netAccording to public information, Tianjin, Shandong, Sichuan, Hunan and other places also have announced to bring up the list of health insurance directory of drugsIt is noteworthy that, only a month in April 2020, there Jiangsu, Shenzhen, Beijing and other places not suspended by the consistency of the evaluation of the product, about the number of species in about 1000, involves nearly 600 companiesFor example, April 13, Beijing issued "on the suspension of part of the notification does not pass the conformance assessment product procurement functions within the scope of the State Central Purchasing" shows that Beijing will not suspend procurement over 843 varieties comment, Harbin Pharmaceutical shares involves part A-share listed companiesApril 17, Jiangsu Province Public Resource Exchange Center issued "on the part of the public not to suspend procurement of quality and efficacy of generic drugs through consistent evaluation of drugs." Suspend purchases of up to 152 drugs, including amoxicillin, omeprazole enteric-coated capsules, escitalopram oxalate tablets, meloxicam tablets, sodium bicarbonate tablets, cephalexin capsules, levetiracetam sheet, involving Medicines, drug, stone four-drug, such as a public North China pharmaceutical pharmaceutical companiesIn fact, there are Jiangxi, Hubei, Shandong, Heilongjiang, Beijing, Shanghai, Guangdong, more than 20 provinces and cities had started to evaluate the agreement with the generic name of three pharmaceutical companies, no longer procurement policy is not consistent evaluation of varieties tooThe future, as more and more over the assessment of drugs, national drug Jicai will form a "1 + 3" pattern - one plus three original drug by evaluating the consistency of generic drugs, and there are more appropriate not assessment of competing products had been temporarily excluded from public hospitals, the country 500 billion generics market reshuffle will be intensifiedIn this process, the industry is expected, there will be 90% of the generics out of the market, generics industry concentration will be further strengthened, but not by generics consistency evaluation, there will be first Be eliminated.